Deal · Announced
Buyer not named and Drugs Made In America Acquisition Corp.
First filed 14 Sept 2026, latest filing 21 Oct 2026, 3 filings.
The deal
- Buyer
- Not named
- Target
- Drugs Made In America Acquisition Corp.
- Status
- Announced
- Region
- US
Background As previously disclosed, on April 29, 2026, Drugs Made In America Acquisition Corp., a Cayman Islands exempted company (the "Company" or "DMAA"), entered into a Definitive Merger Agreement (the "Original Agreement") with Power Analytics Global Corp, a Delaware corporation engaged in the business of artificial intelligence, advanced analytics and quantum-resistant security solutions (...
Source: The filing (sec_header)
With a free account
A free account opens 10 full pages a month and lets you follow this page: alerts on the next filing, buyer lists, exports.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.